RAYMOND JAMES & ASSOCIATES - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,077 filers reported holding NOVARTIS A G in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$52,802,333
-5.8%
518,382
-6.9%
0.04%
-4.3%
Q2 2023$56,069,000
+7.5%
556,817
-1.8%
0.05%
+2.2%
Q1 2023$52,147,237
-17.9%
566,741
-22.2%
0.04%
-22.4%
Q4 2022$63,531,953
+6.6%
728,150
-7.1%
0.06%
-3.3%
Q3 2022$59,600,000
-7.6%
784,118
+2.8%
0.06%
-4.8%
Q2 2022$64,478,000
-17.5%
762,796
-14.4%
0.06%
-4.5%
Q1 2022$78,174,000
+6.4%
890,881
+6.1%
0.07%
+11.9%
Q4 2021$73,462,000
+8.4%
839,860
+1.4%
0.06%
-3.3%
Q3 2021$67,743,000
-10.4%
828,353
-0.0%
0.06%
-11.6%
Q2 2021$75,590,000
-4.2%
828,468
-10.2%
0.07%
-13.8%
Q1 2021$78,880,000
-31.8%
922,781
-24.7%
0.08%
-37.0%
Q4 2020$115,711,000
+14.7%
1,225,371
+5.6%
0.13%
+0.8%
Q3 2020$100,880,000
-9.9%
1,160,088
-9.5%
0.13%
-16.0%
Q2 2020$111,949,000
+7.0%
1,281,769
+1.0%
0.15%
-9.6%
Q1 2020$104,665,000
-8.4%
1,269,450
+5.1%
0.17%
+14.5%
Q4 2019$114,324,000
+11.2%
1,207,352
+2.0%
0.14%
+1.4%
Q3 2019$102,820,000
-31.2%
1,183,198
-27.8%
0.14%
-33.8%
Q2 2019$149,549,000
-0.0%
1,637,825
+5.3%
0.22%
-4.8%
Q1 2019$149,551,000
+15.1%
1,555,554
+2.7%
0.23%
+0.4%
Q4 2018$129,954,000
+2.4%
1,514,442
+2.9%
0.23%
+15.3%
Q3 2018$126,865,000
+55.8%
1,472,439
+36.6%
0.20%
+43.1%
Q2 2018$81,431,000
-12.0%
1,077,989
-5.8%
0.14%
-17.5%
Q1 2018$92,521,000
-3.4%
1,144,346
+0.3%
0.17%
-5.7%
Q4 2017$95,820,000
+2.5%
1,141,247
+4.8%
0.18%
-5.9%
Q3 2017$93,471,000
+0.2%
1,088,773
-2.5%
0.19%
-7.4%
Q2 2017$93,241,000
-30.1%
1,117,052
-37.8%
0.20%
-34.8%
Q1 2017$133,400,000
+16.6%
1,796,145
+14.3%
0.31%
+6.2%
Q4 2016$114,452,000
+59.8%
1,571,273
+73.2%
0.29%
+49.7%
Q3 2016$71,629,000
+36.0%
907,151
+42.1%
0.20%
+18.2%
Q2 2016$52,669,000
+28.2%
638,334
+12.5%
0.16%
+18.7%
Q1 2016$41,098,000
-14.2%
567,343
+1.9%
0.14%
-18.7%
Q4 2015$47,900,000
-9.4%
556,720
-3.3%
0.17%
-20.8%
Q3 2015$52,897,000
-4.3%
575,469
+2.3%
0.22%
+1.9%
Q2 2015$55,298,000
+1.2%
562,315
+1.5%
0.21%
-11.7%
Q1 2015$54,648,000
+21.2%
554,186
+13.9%
0.24%
+9.1%
Q4 2014$45,099,000
+5.3%
486,713
+7.0%
0.22%
-10.6%
Q3 2014$42,828,000
+11.5%
454,984
+7.2%
0.25%
+3.8%
Q2 2014$38,408,000
+19.4%
424,254
+12.1%
0.24%
+7.2%
Q1 2014$32,175,000
+14.1%
378,438
+7.9%
0.22%
+4.7%
Q4 2013$28,195,000
+12.0%
350,774
+6.9%
0.21%
-2.8%
Q3 2013$25,170,000
+13.3%
328,114
+4.5%
0.22%
+3.3%
Q2 2013$22,212,000314,1340.21%
Other shareholders
NOVARTIS A G shareholders Q3 2022
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders